An observational study in Prostate Cancer, sponsored by AHS Cancer Control Alberta. Completed at 1 site in Canada. Open to male participants. Per ClinicalTrials.gov, last updated 2016-02-24.
Sponsored by AHS Cancer Control Alberta · Observational
Clinical data are being used to build a mathematical model to describe the clinical results of radiotherapy for prostate cancer.
Clinical data (prostate-specific antigen [PSA] response after radiotherapy) are being used to build a mathematical model to describe the clinical results of radiotherapy for prostate cancer.
6,484 studies on the registry are indexed under Prostatic Neoplasms; 1,415 are open to participants now.
This study's enrollment of 1,000 is above the median of 200 across 1,200 observational studies indexed under Prostatic Neoplasms.
Browse Prostatic Neoplasms studies →AHS Cancer Control Alberta is the lead sponsor of 187 studies on the registry; 31 are open to participants now.
Counted across the registry records on this site, refreshed daily.
primary care clinic
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This study is completed, as verified in Dec 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.